Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoidosis

R A DeRemee1

  • 1Division of Pulmonary and Critical Care Medicine and Internal Medicine, Mayo Clinic Rochester, MN 55905.

Mayo Clinic Proceedings
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Sarcoidosis is a systemic disease causing granulomas, often affecting the lungs. Diagnosis involves histopathology, and prednisone treatment is effective for managing symptoms and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trimethoprim-sulphamethoxazole for the treatment of Wegener's granulomatosis.

Rheumatology (Oxford, England)·2003
Same author

Ahead to the past.

Mayo Clinic proceedings·1999
Same author

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group.

American journal of respiratory and critical care medicine·1998
Same author

Dysphoria and sarcoidosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·1998
Same author

Colchicine versus prednisone as treatment of usual interstitial pneumonia.

Mayo Clinic proceedings·1997
Same author

Carcinoid tumors and sarcoidosis--does a link exist?

Mayo Clinic proceedings·1997
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

Area of Science:

  • Pulmonology
  • Immunology
  • Pathology

Background:

  • Sarcoidosis is a systemic granulomatous disease of unknown etiology.
  • It frequently impacts the lungs and intrathoracic lymph nodes in over 90% of cases.
  • Pathological hallmarks include noncaseous granulomas.

Purpose of the Study:

  • To outline the diagnostic criteria for sarcoidosis.
  • To describe the prognostic implications of radiographic staging.
  • To review effective treatment and monitoring strategies.

Main Methods:

  • Utilizing a roentgenographic staging system (Stages I-III) for prognosis assessment.
  • Confirming diagnosis through histopathologic examination.
  • Excluding other causes of noncaseous granulomatous reactions.

Related Experiment Videos

Main Results:

  • Chest roentgenography provides prognostic information, symptom severity, and pulmonary function data.
  • Alternate-day prednisone regimens demonstrate high efficacy in treatment.
  • Serial monitoring via chest X-rays, pulmonary function tests, and serum ACE levels is valuable.

Conclusions:

  • Sarcoidosis diagnosis requires histopathologic confirmation and exclusion of other causes.
  • Radiographic staging aids in understanding disease course and prognosis.
  • Prednisone therapy and regular monitoring are key components of sarcoidosis management.